Informazioni sul dominio e sul sito Web:
asaq.it
Nome del dominio - asaq.it
Titolo del sito - Corsi di formazione: prevenzione infortuni, prevenzione incendi, igienico sanitarie e ambientali
Vai al sito web - Corsi di formazione: prevenzione infortuni, prevenzione incendi, igienico sanitarie e ambientali
Posizione GEO del sito
Posizione Paese - Italy
Città /Paese - Arezzo
Fornitore - Aruba S.p.A.
Site Logo
indirizzo IP:
Server dei nomi di dominio:
dns2.technorail.com dns4.arubadns.cz dns.technorail.com dns3.arubadns.net
Tutti i record:
☆ asaq.it. 3600 IN TXT "v=spf1 include:_spf.aruba.it ~all"
☆ asaq.it. 3600 IN A 89.46.108.50
☆ asaq.it. 3600 IN MX 10 mx.asaq.it.
☆ asaq.it. 3600 IN NS dns2.technorail.com.
☆ asaq.it. 3600 IN NS dns4.arubadns.cz.
☆ asaq.it. 3600 IN NS dns3.arubadns.net.
☆ asaq.it. 3600 IN NS dns.technorail.com.
☆ asaq.it. 3600 IN SOA dns.technorail.com. hostmaster.technorail.com. 1 86400 7200 2592000 3600
Brief facts about asaq:
Artesunate/amodiaquine, sold under the trade name Camoquin among others, is a medication used for the treatment of malaria. It is a fixed-dose combination of artesunate and amodiaquine. Specifically it recommended for acute uncomplicated Plasmodium falciparum malaria. It is taken by mouth. Common side effects include loss of appetite, nausea, abdominal pain, sleepiness, trouble sleeping, and cough. Safety in pregnancy is not clear; however, the medication may be used if others are not possible. It is believed to be safe for use during breastfeeding. Artesunate and amodiaquine are both antimalarial medication; however, work by different mechanisms. Artesunate/amodiaquine was commercially launched in 2007. It is on the World Health Organization's List of Essential Medicines. Artesunate/amodiaquine is available as a generic medication. As of 2014 it is not commercially available in the United States or United Kingdom.
World Health Organization essential medicines
© DMS 2011-